Protara Therapeutics, Inc.
Protara Therapeutics, Inc. scores highest on Torque (61) and lowest on Nitro (13). Its PosiPenta is 36.30 out of 100, weaker than most similar companies.
On the Penta Grid this week, Protara Therapeutics, Inc. is Grid #640 of 837 in the Healthcare sector in United States, and Grid #3,195 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Protara Therapeutics, Inc. | 36.30 | 41 | 29 | 13 | 61 | 38 |
| Compass Therapeutics, Inc. | 39.34 | 40 | 39 | 13 | 51 | 54 |
| Journey Medical Corporation | 45.77 | 15 | 69 | 45 | 43 | 56 |
| Codexis, Inc. | 32.46 | 16 | 46 | 40 | 24 | 37 |
| KORU Medical Systems, Inc. | 48.05 | 9 | 82 | 34 | 57 | 58 |
| WW International, Inc. | 53.66 | 94 | 53 | 37 | 36 | 48 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.71 |
| P/B ratio | 0.85 |
EEarnings
| Trailing EPS | ₹-128.81 |
| Forward EPS | ₹-160.19 |
NNitro
| Price | 219.74 |
| 52-week high | 740.67 |
| 52-week low | 219.74 |
| Fall from 52-week high | 70.3% |
TTorque
| Return on equity (ROE) | -45.80% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | 1.47 |
| Market cap | ₹1,298 Cr |
| Insider holding | 2.30% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Protara Therapeutics, Inc.'s PosiPenta score?
Protara Therapeutics, Inc.'s PosiPenta is 36.30 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Protara Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Protara Therapeutics, Inc. is Grid #640 of 837 in the Healthcare sector in United States, and Grid #3,195 of 4,000 in United States.
Which PosiPenta pillar is strongest for Protara Therapeutics, Inc.?
Torque (durability), with a score of 61 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Protara Therapeutics, Inc.?
Nitro (momentum), with a score of 13 out of 100: much weaker than most similar companies.
Has Protara Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.77 points, from 33.53 to 36.30.
PositoAI is for research and education only and is not investment advice.